Cheapest Compounded Tirzepatide in 2026: Real Prices From Verified Providers
Market snapshot: Compounded tirzepatide pricing ranges from $133/mo (GobyMeds bundle) to $399+/mo at higher doses. But the regulatory environment has changed dramatically — the FDA declared the tirzepatide shortage over in October 2024, and enforcement is active. Here's what's available, what it costs, and what the legal landscape looks like.
If you're searching for "cheapest compounded tirzepatide," you're not alone — it's one of the most searched GLP-1 pricing queries in 2026. But the answer requires more context than a simple price table, because the legal and supply landscape has shifted significantly.
⚠️ Important: The FDA declared the tirzepatide shortage resolved in October 2024. Large-scale (503B) compounding is no longer permitted. Patient-specific (503A) compounding continues under narrow legal conditions. Providers offering compounded tirzepatide are operating in an evolving regulatory environment. See our regulatory update for full details.
Compounded Tirzepatide Pricing (May 2026)
| Provider | Starting Price | Maintenance Price | Format | Notes |
|---|---|---|---|---|
| GobyMeds | $133/mo (bundle) | $133/mo | Injectable | Direct affiliate. 503A+503B. Code x7X72r saves $25. |
| SkinnyRx | From $249/mo | Varies | Injectable, sublingual, tablets | Three format options. Oral tirzepatide NOT from Embody. |
| Yucca Health | $258/mo (6-mo plan) | $258/mo flat | Injectable | Requires 6-month commitment for lowest price. |
| SHED | $297–$299/mo | $399+/mo at 7.5mg+ | Injectable | Dose-dependent pricing increase above 7.5mg. |
Brand-Name Tirzepatide Alternatives
With the regulatory crackdown on compounding, brand-name tirzepatide has become more accessible:
| Option | Monthly Cost | Details |
|---|---|---|
| Zepbound (LillyDirect self-pay) | Check LillyDirect.com | Direct-to-patient pricing. No insurance required. |
| Mounjaro (for T2D) | Insurance-dependent | Tirzepatide for type 2 diabetes. Better insurance coverage than Zepbound. |
| Zepbound KwikPen (Medicare Bridge) | $50/mo | Starting July 1, 2026. Requires Part D + prior authorization. |
| With insurance + savings card | As low as $25/mo | Commercial insurance only. Government plans excluded. |
The cheapest compounded tirzepatide option is GobyMeds at $133/mo. But the cheapest overall tirzepatide will soon be the Medicare Bridge at $50/mo (July 2026) for eligible beneficiaries, or $25/mo with commercial insurance and a savings card. The cost advantage of compounded tirzepatide has narrowed significantly.
What "Starting Price" Really Means
Tirzepatide pricing is particularly tricky because the medication gets more expensive at higher doses. Unlike semaglutide (where many providers offer flat pricing), tirzepatide compounders often charge more as the dose increases:
- Starting doses (2.5–5mg): $133–$299/mo — this is what's advertised
- Maintenance doses (7.5–15mg): $299–$499/mo — this is what you'll actually pay long-term
Always ask: "What will I pay at my target maintenance dose?" Not just the starter price.
Tirzepatide vs. Semaglutide: Cost Decision
If cost is your primary driver, compounded semaglutide is significantly cheaper than compounded tirzepatide ($99–$179/mo vs. $133–$399/mo). The clinical data shows tirzepatide produces more weight loss (~22.5% vs ~15%), but the price difference is substantial.
For patients where maximum efficacy matters and cost is secondary, tirzepatide is the stronger compound. For patients where budget is the constraint, semaglutide delivers excellent results at a lower price point.
The Legal Reality
Compounded tirzepatide exists in a regulatory gray zone in 2026. The FDA has won both district court challenges, the Fifth Circuit is deliberating, and the 503B Bulks List exclusion (proposed April 30, 2026) would permanently close the large-scale pathway. Providers currently offering compounded tirzepatide are operating under 503A patient-specific exemptions with documented medical necessity.
This doesn't mean compounded tirzepatide is immediately unavailable — but it means supply continuity is uncertain, and patients should have a transition plan to brand-name alternatives.
Compare Verified Providers
SkinnyRx
From $249/mo tirzepatide
Injectable, sublingual, and tablet formats. Three delivery methods for tirzepatide.
Learn More Paid linkCompounded medications are not FDA-approved.
Yucca Health
$258/mo (6-mo plan)
Deepest tirzepatide discount with commitment. Both sema and tirz available.
Learn More Paid linkCompounded medications are not FDA-approved.
SHED
From $297/mo
Well-established platform. Note: pricing increases at 7.5mg+ doses.
Learn More Paid link⚠️ Price jumps to $399+/mo at 7.5mg and above
Compounded medications are not FDA-approved.
Embody
$149 first / $299 refills
Injectable semaglutide — for patients considering sema over tirz.
Learn More Paid linkCompounded medications are not FDA-approved.
Compare All GLP-1 Providers Side by Side
See pricing, medications, and ratings for verified telehealth providers.
View Provider Comparison →Sources
- Provider websites: pricing verified May 2026.
- GobyMeds: tirzepatide bundle pricing, verified May 2026.
- LillyDirect: Zepbound pricing, verified May 2026.
- CMS: Medicare GLP-1 Bridge details, Zepbound KwikPen coverage.
- FDA: Tirzepatide shortage resolution and enforcement timeline.
Affiliate Disclosure: Some links on this page are paid affiliate links. If you sign up through them, we may earn a commission at no extra cost to you. This does not influence our editorial content or sourcing.
Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
FDA Notice: Compounded medications referenced in this article are not FDA-approved. Only brand-name GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo) carry FDA approval for their indicated uses.